Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #43,651 to #43,700.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Camptothecin (2 revisions)
  2. Campylobacter (2 revisions)
  3. Campylobacteriosis (patient information) (2 revisions)
  4. Campylobacteriosis medical therapy (2 revisions)
  5. Campylobacteriosis natural history, complications and prognosis (2 revisions)
  6. Campylobacteriosis overview (2 revisions)
  7. Canadian Moonseed (2 revisions)
  8. Canary grass (2 revisions)
  9. Cancer/testis antigen 55 (2 revisions)
  10. Cancer/testis antigen family 45, member a5 (2 revisions)
  11. Cancer CT (2 revisions)
  12. Cancer MRI (2 revisions)
  13. Cancer case study one (2 revisions)
  14. Cancer differential diagnosis (2 revisions)
  15. Cancer echocardiography or ultrasound (2 revisions)
  16. Cancer electrocardiogram (2 revisions)
  17. Cancer laboratory findings (2 revisions)
  18. Cancer of unknown primary origin future or investigational therapies (2 revisions)
  19. Cancer other imaging findings (2 revisions)
  20. Cancer physical examination (2 revisions)
  21. Candida krusei (2 revisions)
  22. Candida parapsilosis (2 revisions)
  23. Candidiasis CT (2 revisions)
  24. Candidiasis case study one (2 revisions)
  25. Candidiasis causes (2 revisions)
  26. Aerosol (2 revisions)
  27. Aesculus (2 revisions)
  28. Aesculus hippocastanum (2 revisions)
  29. Aetiotropic (2 revisions)
  30. Affect control theory (2 revisions)
  31. Affection (2 revisions)
  32. Affective neuroscience (2 revisions)
  33. Affective spectrum (2 revisions)
  34. Afferent lymph vessel (2 revisions)
  35. Afimoxifene (2 revisions)
  36. African American Antiplatelet Stroke Prevention Study (2 revisions)
  37. Afrosoricida (2 revisions)
  38. Afrotheria (2 revisions)
  39. Afterlife (2 revisions)
  40. Agarose gel loading buffer (2 revisions)
  41. Agastache rugosa (2 revisions)
  42. Age of onset (2 revisions)
  43. Aggressive NK-cell leukemia CT (2 revisions)
  44. Aggressive NK-cell leukemia case study one (2 revisions)
  45. Aggressive NK-cell leukemia causes (2 revisions)
  46. Aggressive NK-cell leukemia classification (2 revisions)
  47. Aggressive NK-cell leukemia cost-effectiveness of therapy (2 revisions)
  48. Aggressive NK-cell leukemia differential diagnosis (2 revisions)
  49. Aggressive NK-cell leukemia future or investigational therapies (2 revisions)
  50. Aggressive NK-cell leukemia historical perspective (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)